explore -WSS

explore

author：entertainment 2025-09-03 03:22:01 - browse：69

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Stopping antidepressants leads to symptoms for 1 in 6 patients

hotspot

WSS

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

RaDonda Vaught links Vanderbilt hospital issues to patient death

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Male and female sex labels in research insufficient, scientists say

John Green on his newest strategy for fighting tuberculosis

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

hotspot

explore

entertainment

Virginia high school admissions case could be legal follow

CMS got Medicare Advantage quality rating wrong, judge rules

Walensky prepares to leave CDC — and Congress — behind

Boston's new lab space is opening empty

Medicare proposal to cover medical devices draws a mixed reaction

CMS got Medicare Advantage quality rating wrong, judge rules

Duchenne breakthrough therapy leaves behind pioneering families

Medicare Advantage's lean provider networks lead CMS complaints

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Wikipedia

As AI in medicine takes off, can 'human in the loop' prevent harm?

Pushing for an NIH office for post

UnitedHealth CEO's Medicaid comments send insurer stocks diving

As AI in medicine takes off, can 'human in the loop' prevent harm?

Congress needs to close a vaccine

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

hotspot

Wikipedia

knowledge

explore